Literature DB >> 21909674

A newly isolated Streptomyces sp. CS392 producing three antimicrobial compounds.

Seung Sik Cho1, Yun Hee Choi, Jaya Ram Simkhada, Poonam Mander, Da Jeong Park, Jin Cheol Yoo.   

Abstract

With the aim of isolating new microbes capable of producing strong antimicrobial substances, strain CS392 was screened from 700 soil isolates preserved in our laboratory. The strain was related to genus Streptomyces based on various characteristics. Three highly active antimicrobial compounds, C1, C2 and C3, produced by the strain were purified by solvent extraction followed by silica gel column chromatography. These compounds were highly active against various Gram-positive resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Staphylococcus aureus (VRSA), and vancomycin-resistant Enterococcus (VRE). Among three, C3 was the most active against MRSA and VRSA with minimal inhibitory concentration (MIC) of 2 μg/ml while C2 and C3 had MIC values of 4 μg/ml for the strains. In case of Bacillus subtilis ATCC6633, C1 and C3 were more effective with MIC values of 0.5 μg/ml than C2 with MIC of 2 μg/ml. Those antibiotics were variably active (MIC of 4-32 μg/ml) against Micrococcus luteus ATCC 9341, Enterococcus faecalis ATCC 29212, Mycobacterium smegmatis ATCC 9341 and VRE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909674     DOI: 10.1007/s00449-011-0599-7

Source DB:  PubMed          Journal:  Bioprocess Biosyst Eng        ISSN: 1615-7591            Impact factor:   3.210


  9 in total

1.  Antibacterial metabolites from the Actinomycete Streptomyces sp. P294.

Authors:  Huining Su; Hongwei Shao; Keqin Zhang; Guohong Li
Journal:  J Microbiol       Date:  2016-02-02       Impact factor: 3.422

2.  Fumigant activity of volatiles from Streptomyces alboflavus TD-1 against Fusarium moniliforme Sheldon.

Authors:  Zhifang Wang; Changlu Wang; Fengjuan Li; Zhenjing Li; Mianhua Chen; Yurong Wang; Xi Qiao; Hong Zhang
Journal:  J Microbiol       Date:  2013-08-30       Impact factor: 3.422

3.  Antagonistic activity and mechanism of an isolated Streptomyces corchorusii stain AUH-1 against phytopathogenic fungi.

Authors:  Yong Yang; Shuai-Wen Zhang; Kun-Tai Li
Journal:  World J Microbiol Biotechnol       Date:  2019-09-06       Impact factor: 3.312

4.  New antimicrobial anthraquinone 6,61-bis (1,5,7-trihydroxy-3-hydroxymethylanthraquinone) isolated from Streptomyces sp. isolate ERI-26.

Authors:  V Duraipandiyan; Naif Abdullah Al-Dhabi; S Ignacimuthu
Journal:  Saudi J Biol Sci       Date:  2016-02-10       Impact factor: 4.219

5.  Glycin-rich antimicrobial peptide YD1 from B. amyloliquefaciens, induced morphological alteration in and showed affinity for plasmid DNA of E. coli.

Authors:  Md Saifur Rahman; Yun Hee Choi; Yoon Seok Choi; Jin Cheol Yoo
Journal:  AMB Express       Date:  2017-01-03       Impact factor: 3.298

6.  A novel multifunctional peptide oligomer of bacitracin with possible bioindustrial and therapeutic applications from a Korean food-source Bacillus strain.

Authors:  Yun Hee Choi; Seung Sik Cho; Jaya Ram Simkhada; Md Saifur Rahman; Yoon Seok Choi; Chun Sung Kim; Jin Cheol Yoo
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

7.  Analysis of the Active Constituents and Evaluation of the Biological Effects of Quercus acuta Thunb. (Fagaceae) Extracts.

Authors:  Mi-Hyeon Kim; Dae-Hun Park; Min-Suk Bae; Seung-Hui Song; Hyung-Ju Seo; Dong-Gyun Han; Deuk-Sil Oh; Sung-Tae Jung; Young-Chang Cho; Kyung-Mok Park; Chun-Sik Bae; In-Soo Yoon; Seung-Sik Cho
Journal:  Molecules       Date:  2018-07-19       Impact factor: 4.411

Review 8.  Streptomyces as a Prominent Resource of Future Anti-MRSA Drugs.

Authors:  Hefa Mangzira Kemung; Loh Teng-Hern Tan; Tahir Mehmood Khan; Kok-Gan Chan; Priyia Pusparajah; Bey-Hing Goh; Learn-Han Lee
Journal:  Front Microbiol       Date:  2018-09-24       Impact factor: 5.640

9.  Isolation and characterization of cyclo-(tryptophanyl-prolyl) and chloramphenicol from Streptomyces sp. SUK 25 with antimethicillin-resistant Staphylococcus aureus activity.

Authors:  Muhanna M Alshaibani; Juriyati Jalil; Nik M Sidik; Ruangelie Edrada-Ebel; Noraziah M Zin
Journal:  Drug Des Devel Ther       Date:  2016-05-31       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.